Fraunhofer-Gesellschaft

On June 1, Professor Sanaz Mostaghim took over as the new institute director of the Fraunhofer Institute for Transportation and Infrastructure Systems IVI. In this role, she is working together with Professor Matthias Klingner, the institute’s longstanding director, who will stay on as executive director until the end of the year.

Due to their stability and resistance to water and grease, PFAS chemicals (short for per- and polyfluoroalkyl substances) are used in a wide range industries, but they are harmful to health and the environment. Membranes containing PFAS are used in many semiconductor manufacturing processes, for example. Researchers from the Fraunhofer Institute for Applied Polymer Research IAP have now developed a sustainable alternative in the form of an innovative, PFAS-free membrane. The chemically stable, highly permeable polymer membrane has a pore diameter of approx. seven nanometers and enables filtration of the smallest particulate contaminants. The membrane can be customized to meet specific needs, which makes it easy to integrate the new process into existing systems.

Fraunhofer researchers have developed a technology that uses ultrasound signals for targeted stimulation of certain areas of the brain. A special ultra-sound system with 256 individually controllable transducers makes it possible to target and stimulate individual points deep inside the brain with sound signals. In the future, the innovative 3D sound technology from the Fraunhofer Institute for Biomedical Engineering IBMT could be used to treat diseases and conditions such as epilepsy, Parkinson’s disease, depression, addiction, and even the aftereffects of stroke.

Animal testing has long been a fixture of medical and pharmaceutical research, but alternative methods are growing more and more important. Innovative methods allow for research aimed directly at humans — without using animal testing as an intermediate step. TigerShark Science, a planned Fraunhofer start-up and spin-off of the Fraunhofer Translational Center for Regenerative Therapies TLC-RT at the Fraunhofer Institute for Silicate Research ISC, is taking this kind of approach. TigerShark Science hopes to use skin models grown from human stem cells to significantly reduce animal testing.